About 288,763 results

Psychological intervention looks promising in Crohn’s disease
Laird Harrison

May 27th, 2022 - SAN DIEGO – A combination of cognitive-behavioral therapy and mindfulness meditation could reduce pain and fatigue from Crohn’s disease, researchers say. Patients who followed the program not only felt better but were also more often able to show up for work and leisure activities, compared with a control group assigned to a wait list, said Shmuel Odes, MD, a professor of internal medicine at B.

Race-, ethnicity-based clinical guidelines miss the mark: Study
Jim Kling

May 27th, 2022 - SAN DIEGO – Race-based recommendations and clinical algorithms may be doing more harm than good, according to a systematic review of databases and guidelines. The study found examples of screening recommendations based on race or ethnicity that were likely misleading since these are social constructs that don’t reflect a patient’s individual risk, said Shazia Siddique, MD, who presented the stu.

UCLA Reinstates Mask Mandate as California COVID Cases Surge

May 27th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. LOS ANGELES (AP) — The University of California, Los Angeles said Thursday it will reinstate an indoor mask policy as coronavirus cases surge in the nation's most populous state, which now forecasts hospitalizations will nearly triple in the next month. UCLA's 45,000 students and all faculty, st...

Is Subfertility Linked With Postpartum Mental Illness?

May 27th, 2022 - Mothers with previous subfertility have increased risk for postpartum mental illness, compared with mothers who conceived spontaneously, according to a new study. In a population-based cohort study that examined almost 800,000 births, the adjusted relative risk (RR) for postpartum mental illness was 1.14 in women with subfertility, compared with women without reproductive assistance. The magnit...

FDA Okays IN.PACT 018 Drug-Coated Balloon for PAD

May 27th, 2022 - The US Food and Drug Administration has approved the IN.PACT 018 drug-coated balloon (DCB) for the treatment of peripheral arterial disease, Medtronic announced today. The paclitaxel-coated balloon is indicated for percutaneous transluminal angioplasty of de novo, restenotic, or in-stent restenotic lesions up to 360 mm in length with vessel diameters of 4 to 7 mm, located in the superficial fem...

'Unlimited' Cancer Costs: The Medicare Part D Dilemma

May 27th, 2022 - Learning that a family member has cancer can be devastating enough. Waiting to find out whether a loved one can afford their treatment takes the concern to another level. That was the case for health policy expert Stacie B. Dusetzina, PhD, when her mother was diagnosed with metastatic breast cancer. "There is this period where you are waiting to learn more about the cancer type and treatment op...

Number of US Monkeypox Cases Grows to 10, CDC Says

May 27th, 2022 - Ten monkeypox cases have been identified in eight states, according to the CDC. The CDC website said that as of 5 p.m. Thursday, health officials had identified two cases in Florida, two cases in Utah, and one case each in California, Colorado, Massachusetts, New York, Virginia, and Washington state. CDC Director Rochelle Walensky, MD, said Thursday that most of the cases "are within gay [and] ...

Psychological Intervention Looks Promising in Crohn's Disease

May 27th, 2022 - SAN DIEGO — A combination of cognitive-behavioral therapy and mindfulness meditation could reduce pain and fatigue from Crohn's disease, researchers say. Patients who followed the program not only felt better but were also more often able to show up for work and leisure activities, compared with a control group assigned to a wait list, said Shmuel Odes, MD, a professor of internal medicine at B...

Elderly Still Make Up Most of the COVID-19 Deaths

May 27th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The number of daily COVID-19 deaths is dropping in the United States, but one fact has not changed in two-plus years of the pandemic: The elderly are still most at risk of dying from the virus. The seven-day moving average of COVID-related deaths is now 288, a number far lower than the peaks of ...

New Test Might Transform Male Infertility

May 27th, 2022 - A new study suggests that, at least for certain male patients, the answer to infertility might lie with epigenetics. According to the study, a commercially-available test of epigenetic anomalies — factors that affect how genes express themselves — can grade the likelihood that sperm are viable for conception. "The uniqueness of epigenetics is that some of the abnormalities detected have the pot...

New method allows easy, versatile synthesis of lactone molecules

May 27th, 2022 - LA JOLLA, CA—Chemists at Scripps Research have unveiled a method for turning cheap and widely available chemicals known as dicarboxylic acids into potentially very valuable molecules called lactones. Lactone structures are common in biologically active natural molecules; they can be found, for example, in vitamin C and in the bacterial-derived antibiotic erythromycin. Chemists have long had tec...

Hennepin Healthcare investigators study game to help people quit smoking

May 27th, 2022 - Minneapolis, Minn. - Hennepin Healthcare Research Institute is testing an innovative way to help people quit smoking – by letting them bet on themselves and win real money. It’s part of a new game called QuitBet and it’s being funded by a National Institutes of Health (NIH) research grant administered by researchers at Hennepin Healthcare. Players commit to quit smoking over four weeks and bet ...

Social media data show language related to depression didn’t spike after initial pandemic wave

May 27th, 2022 - Researchers who analyzed language related to depression on social media during the pandemic say the data suggest people learned to cope as the waves wore on. University of Alberta researcher Alona Fyshe and her collaborators at the University of Western Ontario hypothesized that depression-related language would spike during each wave of COVID-19. But their study shows that wasn’t the case. “Th...

MSK scientists identify new — and very common — subtype of prostate cancer

May 27th, 2022 - A previously unknown subtype of hormone-resistant prostate cancer accounts for about 30% of all cases, according to a new study from a team of scientists at Memorial Sloan Kettering Cancer Center (MSK) and Weill Cornell Medicine, published May 27, 2022, in the journal Science. The results could pave the way for targeted therapies for people with this subtype of prostate cancer. Prior to this re...

New liver and kidney disease identified

May 27th, 2022 - Scientists have identified a new disease in a ground-breaking discovery that could help patients with unexplained liver and kidney problems. Experts at Newcastle University, UK, have established the inherited condition, called TULP3-related ciliopathy that causes kidney and liver failure in children and adults. There are numerous reasons for kidney and liver organ failure, which if left untreat...

MU study finds health benefits of ‘aging in place’ at TigerPlace

May 27th, 2022 - COLUMBIA, Mo. -- The American Association of Retired Persons (AARP) found the majority of older adults want to stay in their own home as they age. However, given the natural decline in health that comes with aging, some older adults may have to move into a nursing home or assisted-living facility to receive more intensive levels of care. To help older adults live independently as they ‘age in p...

Previous COVID-19 or MIS-C does not protect kids from Omicron

May 27th, 2022 - Research drawing on the national Overcoming COVID-19 study, led by Boston Children’s Hospital, and the hospital’s own Taking On COVID-19 Together Group provides evidence that children who previously had COVID-19 (or the inflammatory condition MIS-C) are not protected against the newer Omicron variant. Vaccination, however, does afford protection, the study found. The findings, published in Natu...

Follow-up data further support the superior efficacy of cabozantinib in patients with progressive differentiated thyroid cancer

May 27th, 2022 - The most common subtype of thyroid cancer is differentiated thyroid cancer (DTC), which has a good prognosis and a survival rate of over 85%. The initial treatment approach is surgery followed, in some cases, by adjuvant radioactive iodine (RAI) therapy. A subset of patients develop RAI-refractory progressive disease, and, until the advent of multikinase inhibitors, lenvatinib and sorafenib, tr...

Chung-Ang University researchers unravel role of cohesins in embryonic stem cell division

May 27th, 2022 - Chromosomes undergo precise structural changes at a molecular level during the different phases of cell division. These changes occur at a high level of accuracy to prevent genome instability. Genome instability resulting from broken, missing, or rearranged chromosomes has been found to be the root cause of cell death, carcinogenesis, and congenital disorders. Studying genomic instability helps...

ECOG-ACRIN research highlights at ASCO 2022

May 27th, 2022 - Philadelphia, May 27, 2022—Researchers with the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present a wide range of study results at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago and online June 3-7. The data include evaluations of new approaches to cancer treatment, control, care delivery, and health equity. The National Cancer Institute, part of the Na...